Zobrazuji výsledky 1 - 5 z 5 pro vyhledávání 'Seyed Reza Mousavi (13223324)', doba hledání: 0,01 s. Upřesnit hledání
  1. 1
    The non-inferiority margin in Phase III clinical trial of SnaFab compared to Razi antivenom in snakebites.

    The non-inferiority margin in Phase III clinical trial of SnaFab compared to Razi antivenom in snakebites. Autor Seyed Reza Mousavi (13223324)

    Vydáno 2025
    Přidat do oblíbených
    Uloženo v:
  2. 2
    Snakebite severity classification in clinical trial of SnaFab vs. Razi antivenom in snakebite victims [14,57,58].

    Snakebite severity classification in clinical trial of SnaFab vs. Razi antivenom in snakebite victims [14,57,58]. Autor Seyed Reza Mousavi (13223324)

    Vydáno 2025
    Přidat do oblíbených
    Uloženo v:
  3. 3
    Adverse events during follow-up period in Phase III non-inferiority clinical trial of SnaFab compared to Razi antivenom in snakebites.

    Adverse events during follow-up period in Phase III non-inferiority clinical trial of SnaFab compared to Razi antivenom in snakebites. Autor Seyed Reza Mousavi (13223324)

    Vydáno 2025
    Přidat do oblíbených
    Uloženo v:
  4. 4
    Consort Chart of Phase III clinical trial of SnaFab compare to Razi antivenom in snakebites.

    Consort Chart of Phase III clinical trial of SnaFab compare to Razi antivenom in snakebites. Autor Seyed Reza Mousavi (13223324)

    Vydáno 2025
    Přidat do oblíbených
    Uloženo v:
  5. 5
    Demographic information and clinical presentation of victims in Phase III non-inferiority clinical trial of SnaFab compare to Razi antivenom in snakebites.

    Demographic information and clinical presentation of victims in Phase III non-inferiority clinical trial of SnaFab compare to Razi antivenom in snakebites. Autor Seyed Reza Mousavi (13223324)

    Vydáno 2025
    Přidat do oblíbených
    Uloženo v:

Vyhledávací nástroje: